References
- Goodall EF, Morrison KE. Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment. Expert Rev Mol Med 2006; 8: 1–22
- Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzon in amyotrophic lateral sclerosis. ALS/Riluzon Study Group. N Engl J Med 1994; 330: 585–91
- Silani V, Cova L, Corbo M, et al. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet 2004; 364: 200–2
- Chen R, Ende N. The potential for the use of mononuclear cells from human umblical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J Med 2000; 31: 21–30
- Rowland LP. Summing up: an action plan for ALS research. Amyotroph Lateral Scler Other Motor Neuron Disord 2004; 5(suppl 1)141–3
- Silani V, Corbo M. Cell-replacement therapy with stem cells in neurodegenerative disease. Curr Neurovasc Res 2004; 1: 283–9
- Brujin LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004; 27: 723–49
- Giardano A, Galderisi U, Marino IR. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 2007; 211: 27–35
- Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004; 27: 723–49
- Nirmalananthan N, Greensmith L. Amyotrophic lateral sclerosis: recent advances and future therapies. Curr Opin Neurol 2005; 18: 712–19
- Nayak MS, Kim YS, Goldman M, et al. Cellular therapies in motor neuron diseases. Biochim Biophys Acta 2006; 1762: 1128–38
- Jlang Y, Jahagirdar BN, Relnhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41–9
- Hao HN, Zhao J, Thomas RL, et al. Fetal human hematopoietic stem cells can differentiate sequentially into neural stem cells and then astrocytes in vitro. J Hematother Stem Cell Res 2003; 12: 23–32
- Janson CG, Ramesh TM, During MJ, et al. Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis. J Hematother Stem Cell Res 2001; 10: 913–15
- Mazzini L, Fagioli F, Boccaletti R, et al. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4: 133–4
- Mazzini L, Fagioli F, Boccaletti R. Stem-cell therapy in amyotrophic lateral sclerosis. Lancet 2004; 364: 1936–7
- Mazzini L, Mareschi K, Ferero I, et al. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol Res 2006; 28: 523–6
- McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 2002; 26: 459–70
- Sargsyan SA, Monk PN, Shaw PJ. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 2005; 51: 241–53